Dexmedetomidine Premix Formulation

Patent No. EP2648520 (titled "Dexmedetomidine Premix Formulation") was filed by Hospira on Jun 18, 2012. The application was issued on Apr 11, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FRESENIUS KABI DEUTSCHLANDJan 9, 2019FRESENIUS KABI DEUTSCHLAND

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2648520

HOSPIRA
Application Number
EP12823234A
Filing Date
Jun 18, 2012
Status
Revoked
Jan 7, 2022
Publication Date
Apr 11, 2018